Please provide your email address to receive an email when new articles are posted on . Among the top stories in cardiology last week were reports from Healio's live coverage of the American College ...

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Human neutrophil peptide-1 (HNP-1) is a commonly investigated therapeutic agent. However, its role in ...

At baseline, 1905 (12%) of VALUE patients were identified with LVH and 12,980 (85%) without LVH. Data were absent for 374 (2%) patients. The VALUE patients for LVH analysis thus comprised a larger ...

A randomized controlled study recently published in Ethnicity & Disease in their Autumn 2019 Hypertension issue found that the Transcendental Meditation (TM) technique helps to prevent abnormal ...

The three-decade-old international cutpoint for diagnosing children and adolescents with an enlarged heart misclassifies normal heart size as cardiac damage in adolescents, a paper published in the ...

1 Clinical Centra of Sports Medicine and Rehabilitation of Tbilisi State Medical University, Tbilisi, Georgia 2 Tbilisi State Medical University, Tbilisi, Georgia 3 Medical Service of Georgian ...

Objectives American-style football (ASF) athletes are at risk for the development of concentric left ventricular hypertrophy (C-LVH), an established cardiovascular risk factor in the general ...

Background A 64-year-old male was observed as an outpatient with atypical, non-exercise-induced chest pain and palpitations. He had arterial hypertension and marked concentric left ventricular ...

Elevated left ventricular mass, known as left-ventricular hypertrophy, is a stronger predictor of coronary artery disease-related death and heart failure than coronary artery calcium score, according ...

Left ventricular noncompaction is characterized by deep trabeculations in the LV endocardium in association with left ventricular hypertrophy, dilation or hypertrophy/dilation. Noncompaction of the ...

In fact, among Medicare beneficiaries aged 65 years or older, the incidence of transthyretin cardiac amyloidosis (ATTR-CM) diagnoses rose from about 10.1 per 100,000 person-years ...